Article Details
Retrieved on: 2024-03-19 19:05:31
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a study on using circulating tumor DNA (ctDNA) from liquid biopsies to monitor treatment effectiveness and predict prognosis in gastroesophageal cancers, particularly in relation to immunotherapy drugs like nivolumab.
Article found on: www.hopkinsmedicine.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here